Davide Arillotta

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

Davide Arillotta, Giuseppe Floresta, Amira Guirguis et al. · Brain Sciences · 2023 · 92 citations · Full text

Medicine, Endocrinology, Pharmacology +16

The clinical challenges of synthetic cathinones

Fabrizio Schifano, Flavia Napoletano, Davide Arillotta et al. · British Journal of Clinical Pharmacology · 2019 · 72 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis

Amira Guirguis, Stefania Chiappini, GD Papanti P et al. · European Neuropsychopharmacology · 2024 · 58 citations · Full text

Pharmacy, Endocrinology, Pharmacology +17

Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach

Davide Arillotta, Giuseppe Floresta, Guy Pelletier et al. · Brain Sciences · 2024 · 54 citations · Full text

Nursing, Pharmacology, Psychology +17

Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study

Laura Fusar‐Poli, Natascia Brondino, Matteo Rocchetti et al. · Psychiatry Research · 2019 · 47 citations

Medicine, Pediatrics, Psychiatry +15